Farallon Capital Management LLC Grows Position in Encompass Health Co. (NYSE:EHC)

Farallon Capital Management LLC lifted its holdings in shares of Encompass Health Co. (NYSE:EHC - Free Report) by 15,266.7% in the fourth quarter, according to its most recent filing with the SEC. The firm owned 461,000 shares of the company's stock after acquiring an additional 458,000 shares during the period. Farallon Capital Management LLC owned approximately 0.46% of Encompass Health worth $42,573,000 as of its most recent filing with the SEC.

Other hedge funds and other institutional investors also recently made changes to their positions in the company. Charles Schwab Investment Management Inc. increased its position in shares of Encompass Health by 0.7% during the 4th quarter. Charles Schwab Investment Management Inc. now owns 644,764 shares of the company's stock worth $59,544,000 after purchasing an additional 4,345 shares in the last quarter. Merit Financial Group LLC acquired a new stake in shares of Encompass Health during the 4th quarter worth about $374,000. BI Asset Management Fondsmaeglerselskab A S acquired a new stake in shares of Encompass Health during the 4th quarter worth about $4,160,000. MassMutual Private Wealth & Trust FSB increased its position in shares of Encompass Health by 87.8% during the 4th quarter. MassMutual Private Wealth & Trust FSB now owns 293 shares of the company's stock worth $27,000 after purchasing an additional 137 shares in the last quarter. Finally, US Bancorp DE increased its position in shares of Encompass Health by 9.6% during the 4th quarter. US Bancorp DE now owns 1,380 shares of the company's stock worth $127,000 after purchasing an additional 121 shares in the last quarter. 97.25% of the stock is owned by institutional investors.

Encompass Health Trading Up 0.5%

Encompass Health stock traded up $0.54 during midday trading on Friday, hitting $116.45. 623,027 shares of the stock were exchanged, compared to its average volume of 687,253. The company has a fifty day simple moving average of $103.44 and a two-hundred day simple moving average of $99.99. Encompass Health Co. has a 52 week low of $82.74 and a 52 week high of $118.27. The stock has a market capitalization of $11.74 billion, a PE ratio of 26.11, a P/E/G ratio of 2.31 and a beta of 0.91. The company has a quick ratio of 1.04, a current ratio of 1.05 and a debt-to-equity ratio of 0.84.

Encompass Health (NYSE:EHC - Get Free Report) last announced its quarterly earnings results on Thursday, April 24th. The company reported $1.37 earnings per share for the quarter, beating analysts' consensus estimates of $1.19 by $0.18. Encompass Health had a net margin of 8.48% and a return on equity of 17.56%. The firm had revenue of $1.46 billion for the quarter, compared to analyst estimates of $1.43 billion. During the same quarter in the previous year, the firm posted $1.12 earnings per share. The business's revenue was up 10.6% on a year-over-year basis. Equities research analysts anticipate that Encompass Health Co. will post 4.8 EPS for the current fiscal year.

Encompass Health Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Tuesday, July 15th. Investors of record on Tuesday, July 1st will be paid a $0.17 dividend. The ex-dividend date is Tuesday, July 1st. This represents a $0.68 annualized dividend and a dividend yield of 0.58%. Encompass Health's dividend payout ratio (DPR) is presently 14.05%.

Analyst Ratings Changes

Several research firms have weighed in on EHC. Truist Financial restated a "buy" rating and issued a $135.00 price objective (up previously from $116.00) on shares of Encompass Health in a research report on Monday, April 28th. UBS Group raised their price objective on shares of Encompass Health from $117.00 to $130.00 and gave the company a "buy" rating in a research report on Monday, April 28th. Royal Bank of Canada raised their price objective on shares of Encompass Health from $110.00 to $125.00 and gave the company an "outperform" rating in a research report on Monday, April 28th. KeyCorp lifted their price target on shares of Encompass Health from $120.00 to $122.00 and gave the stock an "overweight" rating in a research report on Friday, April 25th. Finally, William Blair reiterated an "outperform" rating on shares of Encompass Health in a research report on Friday, February 7th. Nine equities research analysts have rated the stock with a buy rating and one has given a strong buy rating to the stock. Based on data from MarketBeat.com, Encompass Health has an average rating of "Buy" and a consensus target price of $120.86.

Insider Activity at Encompass Health

In other Encompass Health news, CAO Andrew L. Price sold 5,042 shares of the firm's stock in a transaction that occurred on Thursday, February 13th. The shares were sold at an average price of $98.29, for a total transaction of $495,578.18. Following the completion of the transaction, the chief accounting officer now owns 69,164 shares in the company, valued at approximately $6,798,129.56. This trade represents a 6.79% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, insider Elissa Joy Charbonneau sold 4,279 shares of the firm's stock in a transaction that occurred on Tuesday, May 6th. The stock was sold at an average price of $116.61, for a total transaction of $498,974.19. Following the sale, the insider now directly owns 11,958 shares of the company's stock, valued at approximately $1,394,422.38. This trade represents a 26.35% decrease in their position. The disclosure for this sale can be found here. Over the last three months, insiders have sold 19,321 shares of company stock worth $2,142,452. Corporate insiders own 2.00% of the company's stock.

Encompass Health Company Profile

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.